Skip to main content

News Archive

News Archive - Jackie Carr

UC San Diego Health and Vantage Oncology Announce Cancer Care Collaboration

March 7, 2016

UC San Diego Health and Vantage Oncology are collaborating to provide comprehensive cancer care services to patients in Imperial Valley. Through a joint venture, UC San Diego Health and Vantage will operate Imperial Valley Radiation Oncology. Patients will have access to advanced radiation technologies as well as clinical trial interventions and specialty care consultations with UC San Diego Health and Moores Cancer Center.

New Living Donor Option for Liver Transplantation at UC San Diego Health

March 1, 2016

Nationally, more than 15,000 patients are waiting for a liver transplant. Approximately 6,300 persons each year will receive a new liver; 1,400 die waiting. In California, one in four listed for liver transplant will die before an organ becomes available. Fortunately, living donation is now a lifesaving option at UC San Diego Health.

Patty Maysent Named CEO of UC San Diego Health

January 21, 2016

Patty Maysent has accepted the position as CEO of UC San Diego Health, the region’s only academic health system. Her appointment was approved by the UC Board of Regents and will commence January 21, 2016.

Neurosurgeons Evaluate Precision Laser Treatment Of Brain Tumors at UC San Diego Health

January 13, 2016

Neurosurgeons at UC San Diego Health have initiated a landmark, multi-center study to evaluate how the treatment of brain tumors using the NeuroBlate system, a minimally invasive, FDA-approved laser device, impacts the quality of life of patients.

UC San Diego Health and Sharp HealthCare Announce Joint Liver Transplantation Program

January 11, 2016

UC San Diego Health and Sharp HealthCare have formed a joint program to enhance liver transplantation service¬¬s in San Diego by combining resources, collaborating on research and expanding specialized liver care. The alliance is expected to strengthen clinical services for patients with end-stage liver disease while reducing costs.

UC San Diego and El Centro Regional Medical Center Expand Clinical Affiliation

December 16, 2015

UC San Diego Health and the City of El Centro have entered the next phase of a comprehensive management services relationship with El Centro Regional Medical Center (ECRMC). Under a new agreement, UC San Diego Health will provide strategic planning and management and consulting services to the ECRMC Board of Trustees and hospital leadership. UC San Diego Health and ERCMC will align administrative expertise, business and clinical initiatives with the goals of enhancing ECRMC’s ability to deliver high-quality, integrated and cost-effective care to patients in the Imperial Valley.

New Incision-Free Weight Loss Option at UC San Diego Health

December 10, 2015

Patients seeking rapid but safe weight loss have a new option at the Bariatric Metabolic Institute (BMI) at UC San Diego Health. During an outpatient procedure, surgeons place an adjustable saline balloon in the stomach. The volume and shape of the balloon take up space in the stomach, which encourages food portion control. The device, called Orbera, has been shown to reduce total body weight by 10 percent.

Tri-City Healthcare District and UC San Diego Health Enter into an Exclusive Affiliation

October 14, 2015

UC San Diego Health and Tri-City Healthcare District announced today that they have entered into an exclusive, long-term strategic affiliation designed to enhance the delivery of high quality health care to patients in North San Diego County.

Down Syndrome Research Untangles Therapeutic Possibilities for Alzheimer’s

September 17, 2015

More than five million Americans are living with Alzheimer’s disease (AD). Of them, 400,000 also have Down syndrome. Both groups have similar looking brains with higher levels of the protein beta amyloid. In fact, patients with Down syndrome develop the abnormal protein at twice the rate. Results of a pilot study confirms the pathogenic role of beta amyloid in dementia as seen in both AD and Down syndrome.

Novel Therapeutic Agent for Pediatric Cancer Developed at UC San Diego in Clinical Trials

August 11, 2015

Donald L. Durden, MD, PhD, pediatric researcher at University of California, San Diego School of Medicine and Moores Cancer Center has identified and developed a novel therapeutic target for neuroblastoma, the second most common solid-tumor childhood cancer. The agent, named SF1126, acts by inhibiting the part of the cancer cell engine that promotes tumor angiogenesis and growth.
Category navigation with Social links